Israel Englander Aptinyx Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.12 - $0.69 $133,022 - $764,879
-1,108,521 Reduced 83.12%
225,101 $28,000
Q4 2022

Feb 14, 2023
BUY
$0.23 - $0.34 $29,816 - $44,075
129,635 Added 10.77%
1,333,622 $391,000
Q3 2022

Nov 14, 2022
SELL
$0.35 - $0.72 $109,458 - $225,172
-312,739 Reduced 20.62%
1,203,987 $443,000
Q2 2022

Aug 15, 2022
BUY
$0.38 - $2.58 $77,007 - $522,837
202,650 Added 15.42%
1,516,726 $846,000
Q1 2022

May 16, 2022
BUY
$2.27 - $3.62 $152,387 - $243,014
67,131 Added 5.38%
1,314,076 $2.98 Million
Q4 2021

Feb 14, 2022
BUY
$2.11 - $3.0 $433,716 - $616,659
205,553 Added 19.74%
1,246,945 $3.33 Million
Q3 2021

Nov 15, 2021
SELL
$2.21 - $2.89 $190,767 - $249,464
-86,320 Reduced 7.65%
1,041,392 $2.44 Million
Q2 2021

Aug 16, 2021
SELL
$2.39 - $3.5 $684,383 - $1 Million
-286,353 Reduced 20.25%
1,127,712 $3.19 Million
Q1 2021

May 17, 2021
SELL
$2.86 - $4.33 $1.26 Million - $1.9 Million
-438,880 Reduced 23.69%
1,414,065 $4.24 Million
Q4 2020

Feb 16, 2021
BUY
$2.93 - $4.3 $3.31 Million - $4.86 Million
1,131,068 Added 156.68%
1,852,945 $6.41 Million
Q3 2020

Nov 16, 2020
BUY
$3.05 - $4.99 $105,429 - $172,489
34,567 Added 5.03%
721,877 $2.44 Million
Q2 2020

Aug 14, 2020
BUY
$1.99 - $4.4 $720,467 - $1.59 Million
362,044 Added 111.31%
687,310 $2.87 Million
Q1 2020

May 14, 2020
BUY
$1.81 - $5.03 $456,876 - $1.27 Million
252,418 Added 346.5%
325,266 $703,000
Q4 2019

Feb 14, 2020
SELL
$2.84 - $4.25 $99,201 - $148,452
-34,930 Reduced 32.41%
72,848 $249,000
Q3 2019

Nov 14, 2019
SELL
$3.0 - $4.08 $179,715 - $244,412
-59,905 Reduced 35.73%
107,778 $376,000
Q2 2019

Aug 15, 2019
BUY
$2.95 - $4.38 $390,276 - $579,460
132,297 Added 373.87%
167,683 $560,000
Q2 2019

Aug 14, 2019
SELL
$2.95 - $4.38 $187,749 - $278,760
-63,644 Reduced 64.27%
35,386 $77,000
Q1 2019

May 14, 2019
BUY
$3.99 - $19.33 $330,954 - $1.6 Million
82,946 Added 515.71%
99,030 $401,000
Q4 2018

Feb 14, 2019
BUY
$16.15 - $28.93 $259,756 - $465,310
16,084 New
16,084 $266,000
Q3 2018

Nov 14, 2018
SELL
$20.21 - $31.85 $2.19 Million - $3.45 Million
-108,188 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$19.83 - $24.17 $2.15 Million - $2.61 Million
108,188 New
108,188 $2.62 Million

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email